动态功能网络连接性及其与阿尔茨海默病中脂质代谢的关联
Feifei Zang1, Xinyi Liu1, Dandan Fan1
1Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
CNS neuroscience & therapeutics
|September 20, 2024
概括
阿尔茨海默病 (AD) 谱种群中的动态功能网络连接 (dFNC) 变化与脂质代谢有关. 改变的dFNC模式与APOE-ε4状态,遗传风险和脂质水平相关,影响认知.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是认知能力下降.
- 动态功能网络连接 (dFNC) 反映了大脑随着时间的推移而变化的功能组织.
- 脂质代谢在大脑健康中起着至关重要的作用,并与阿尔茨海默病的发病有关.
研究的目的:
- 在AD频谱中调查dFNC轨迹特征的变化.
- 探索dFNC模式与脂质代谢相关因素之间的关联.
- 了解这些因素如何影响AD的认知功能.
主要方法:
- 利用滑窗方法分析阿尔茨海默氏病神经成像计划的242名AD频谱受试者的全脑dFNC.
- 使用的支持矢量机器用于根据异常的dFNC对AD频谱种群进行分类.
- 进行调解分析,检查脂质指标,dFNC,脑脊液 (CSF) 生物标志物和认知表现之间的关系.
主要成果:
- 确定了两个不同的dFNC状态:状态I (频繁,弱连接) 和状态II (不频繁,强连接).
- 在AD前的受试者更喜欢状态I,而AD患者在状态II中花费了更多时间.
- APOE-ε4载体,高多基因分数和高血清脂质水平与网络中断有关,这可能表明I状态的补偿机制,并在II状态中调解认知结果.
结论:
- 在APOE-ε4的个体中,dFNC时间空间模式被破坏,高多基因分数和血清脂质升高.
- 这些发现强调了脂质相关机制在AD频谱内的动态网络重组中的作用.
- 了解这些动态网络变化为AD病理生理学和潜在的治疗点提供了洞察力.
更多相关视频
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
981
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
440
相关概念视频
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
